VBIO — Valion Bio Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Valion Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.49 | -10.1 | -8.24 | -5.66 | -7.99 |
| Depreciation | |||||
| Non-Cash Items | 3.28 | 0.562 | 0.477 | 0.932 | 0.537 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.403 | 0.605 | -0.752 | -1 | 0.452 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -5.61 | -8.92 | -8.51 | -5.72 | -7 |
| Capital Expenditures | — | -0.011 | -0.118 | — | -0.581 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.124 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.011 | -0.118 | — | -0.705 |
| Financing Cash Flow Items | — | -0.584 | 0 | -0.049 | -0.136 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 17.5 | -0.528 | 8.51 | 4.33 | 18.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 11.9 | -9.46 | -0.122 | -1.39 | 10.6 |